Skip to main content
George Molina, MD, General Surgery, Boston, MA

GeorgeMolinaMDMPH

General Surgery Boston, MA

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)

Pancreatic, Hepatobiliary/GI Surgical Oncologist

Dr. Molina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Molina's full profile

Already have an account?

  • Office

    Massachusetts General Hospital
    55 Fruit St
    Boston, MA 02114
    Phone+1 617-726-2000

Summary

  • Dr. George Molina is a surgical oncologist in Boston, MA and is affiliated with Brigham and Women's Hospital with Dana-Farber Cancer Institute. He received his medical degree from Harvard Medical School. He is fluent in Spanish. He specializes in hepatobiliary surgery, pancreas, and surgical oncology (other than breast).

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Complex General Surgical Oncology, 2018 - 2020
  • Massachusetts General Hospital
    Massachusetts General HospitalChief Residency, Surgery, 2017 - 2018
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Surgery, 2011 - 2017
  • Harvard Medical School
    Harvard Medical SchoolClass of 2011
  • Harvard School of Public Health
    Harvard School of Public HealthMPH, Quantitative Methods, 2009 - 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2025
  • RI State Medical License
    RI State Medical License 2022 - 2024
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Culturally Competent Science  
    Diego B Lopez, George Molina, JAMA

Lectures

  • Use of immunotherapy for stage-III and IV melanoma and likelihood of regional and distant lymph node resection and surgical resection for distant metastasis. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • C-section Target Rates May Be Set Too Low
    C-section Target Rates May Be Set Too LowDecember 1st, 2015

Professional Memberships

Other Languages

  • Spanish